Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
---|
12/08/2005 | WO2005116237A2 Site specific incorporation of heavy atom-containing unnatural amino acids into proteins for crystal structure determination |
12/08/2005 | WO2005116230A2 Golgi apparatus regenerated in vitro method for production and use thereof |
12/08/2005 | WO2005116227A1 A method to produce succinic acid from raw hydrolysates |
12/08/2005 | WO2005116217A1 Glucose isomerase mutants |
12/08/2005 | WO2005116215A1 Improvement to the resistance of a plant to destructive insects |
12/08/2005 | WO2005116214A2 Destructive insect-inducible promoters and uses thereof |
12/08/2005 | WO2005116213A2 Directed evolution of proteins |
12/08/2005 | WO2005116212A2 Treatment of neurodegenerative disease through intracranial delivery of sirna |
12/08/2005 | WO2005116211A1 9-fatty acid hydroperoxide lyase genes |
12/08/2005 | WO2005116206A1 Improved nitrile hydratase |
12/08/2005 | WO2005116201A1 TYROSINE KINASE TNK FOR USE AS INHIBITOR FOR NUCLEAR TRANSCRIPTION FACTOR KAPPA B (NFκB) |
12/08/2005 | WO2005116200A2 Nucleic acids and polypeptides involved in the production of cryptophycin |
12/08/2005 | WO2005116199A2 Tobacco nicotine demethylase genomic clone and uses thereof |
12/08/2005 | WO2005116198A2 Methods of 1,3-enyne preparation using copper (i) catalysts |
12/08/2005 | WO2005116197A2 Adamts-8 proteins and uses thereof |
12/08/2005 | WO2005116196A2 Production of peroxidase from plant cell and callus cultures |
12/08/2005 | WO2005116195A2 Method for identifying pde5-modulators |
12/08/2005 | WO2005116082A1 2-cysteine peroxiredoxin complex exhibiting function acting as molecular chaperone and uses thereof |
12/08/2005 | WO2005116005A1 Epigallocatechin dimer and trimer having lipase inhibitory activity and/or antioxidative activity |
12/08/2005 | WO2005115461A2 Pharmaceutical composition for modulating the activity of triglyceride hydrolase |
12/08/2005 | WO2005115458A2 Methods and compositions related to regulation of nucleo-cytoplasmic localization of e1 dna helicase in papillomaviruses |
12/08/2005 | WO2005089737A3 Materials and methods for inhibiting wip1 |
12/08/2005 | WO2005089411A3 Tissue products from animals lacking functional alpha 1,3 galactosyl transferase |
12/08/2005 | WO2005087947A3 Bioengineered proteolytic enzymes with enhanced specificity for cytokine receptors |
12/08/2005 | WO2005087916A3 Novel xylanases and their use |
12/08/2005 | WO2005085431A3 Mutants of o6-alkylguanine-dna alkyltransferase |
12/08/2005 | WO2005078075A3 Hybrid proteins of active-site serine beta-lactamase |
12/08/2005 | WO2005067410A3 Synthetic nucleic acids from aquatic species |
12/08/2005 | WO2005060721A3 Manipulation of rna interference through modulation of armitage activity |
12/08/2005 | WO2005047526A3 Method for identifying inhibitors using a homology model of polo-like kinase 1 |
12/08/2005 | WO2005047469A3 PORCINE ISOGLOBOSIDE 3 SYNTHASE PROTEIN, cDNA, GENOMIC ORGANIZATION, AND REGULATORY REGION |
12/08/2005 | WO2005014779A9 Cyclodextrin affinity purification |
12/08/2005 | WO2005005627A3 Applications of a new class of enzymes: sulfiredoxines. |
12/08/2005 | WO2004111220A8 Proteases |
12/08/2005 | WO2004066945A3 Enzymes and the nucleic acids encoding them and methods for making and using them |
12/08/2005 | WO2003045323A3 Anti-angiogenesis methods, compositions and uses therefor |
12/08/2005 | US20050273886 Plastidic phosphoglucomutase genes |
12/08/2005 | US20050273885 Synthesis of long-chain polyunsaturated fatty acids by recombinant cells |
12/08/2005 | US20050273884 PUFA polyketide synthase systems and uses thereof |
12/08/2005 | US20050273883 Pufa polyketide synthase systems and uses thereof |
12/08/2005 | US20050273880 Polypeptides having oxaloacetate hydrolase activity and nucleic acids encoding same |
12/08/2005 | US20050273879 Phytate polynucleotides and methods of use |
12/08/2005 | US20050272780 Small molecule inhibitors of rotamase enzyme activity |
12/08/2005 | US20050272683 Antisense oligonucleotides against thymidylate synthase |
12/08/2005 | US20050272633 Derivatives of the nf-kappab inducing enzyme, their preparation and use |
12/08/2005 | US20050272138 Method of preparing cross-linked enzyme particles |
12/08/2005 | US20050272137 Fermentation with a phytase |
12/08/2005 | US20050272133 A C9-deoxomeridamycin, used as a neuroregenerative agent |
12/08/2005 | US20050272129 Filamentous fungus belonging to a species Colletotrichum gloeosporioides or Aspergillus niger; improved biomass production in solid and liquid culture; for biocontrol |
12/08/2005 | US20050272128 Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity |
12/08/2005 | US20050272121 Site specific incorporation of heavy atom-containing unnatural amino acids into proteins for structure determination |
12/08/2005 | US20050272119 Polypeptides having 2',5'-oligoadenylate phosphodiesterase activity, antibodies against polypeptides, polynucleotides coding for polypeptides, recombinant plasmid DNAs into which polynucleotides have been inserted; for searching for antitumor agents, viricides |
12/08/2005 | US20050272117 Method |
12/08/2005 | US20050272114 wherein mutant hydrolase forms stable bond with rhodococcus dehalogenase substrate; beta-lactamases; fustion proteins; cell labelling; tissue target therapy |
12/08/2005 | US20050272111 Renilla reniformis fluorescent proteins, nucleic acids encoding the fluorescent proteins and the use thereof in diagnostics, high throughput screening and novelty items |
12/08/2005 | US20050272092 Novel gene having reverse transcriptas motif |
12/08/2005 | US20050272082 Alternatively spliced isoform of acetyl-CoA carboxylase 2 (ACC2) |
12/08/2005 | US20050272077 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases |
12/08/2005 | US20050272074 Compositions and methods for reverse transcription |
12/08/2005 | US20050272072 Ligand-dependent protein splicing |
12/08/2005 | US20050272066 Using f-box containing protein as tool in treatment and prevention of infection, cardiovascular, cell proliferative and nervous system disorders |
12/08/2005 | US20050272064 Enzymatic polypeptide comprising halogenase activity for use in production of 4-substituted-3-butyric acid derivatives and vicinal cyano, hydroxyl substituted carboxylic acid esters; bioremediation; pollution control |
12/08/2005 | US20050272058 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
12/08/2005 | US20050272041 isolated polynucleotide encoding Enzymatic proteins for use in food processing, paper making and recycling |
12/08/2005 | US20050271769 Enzyme |
12/08/2005 | US20050271690 Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them |
12/08/2005 | US20050271679 Recombinant adenylate cyclase toxin of Bordetella induces T cell responses against tumoral antigens |
12/08/2005 | US20050271668 Janus family kinases and identification of immune modulators |
12/08/2005 | US20050271666 Regulation of human protein phosphatase IIc-like enzyme |
12/08/2005 | US20050271647 Chimeric pro-caspases and methods of using same |
12/08/2005 | US20050271644 Vitamin K epoxide recycling polypeptide VKORC1, a therapeutic target of coumarin and their derivatives |
12/08/2005 | US20050271628 Negative-sense RNA virus vector for nerve cell |
12/08/2005 | CA2822895A1 Influenza hemagglutinin and neuraminidase variants |
12/08/2005 | CA2604243A1 Compositions with modified nucleases targeted to viral nucleic acids and methods of use for prevention and treatment of viral diseases |
12/08/2005 | CA2590553A1 Method for identifying pde5-modulators |
12/08/2005 | CA2567624A1 Site specific incorporation of heavy atom-containing unnatural amino acids into proteins for crystal structure determination |
12/08/2005 | CA2565098A1 Treatment of neurodegenerative disease through intracranial delivery of sirna |
12/08/2005 | CA2564585A1 Methods of 1,3-enyne preparation using copper (i) catalysts |
12/08/2005 | CA2562683A1 Adamts-8 proteins and uses thereof |
12/07/2005 | EP1602728A1 Alcohol dehydrogenase gene of acetic acid bacterium |
12/07/2005 | EP1602725A2 Abasic-nucleotide containing enzymatic nucleic acid |
12/07/2005 | EP1602722A1 Process for producing microbial transglutaminase |
12/07/2005 | EP1602721A1 Koji mold-origin phospholipase a sb 2 /sb |
12/07/2005 | EP1602719A1 Control of transglutaminase catalyzed protein modification by selective irreversible transglutaminase inhibitors |
12/07/2005 | EP1602718A1 Neutral phenol oxidase |
12/07/2005 | EP1602704A1 Antioxidant, skin preparation for external use, cosmetic and food |
12/07/2005 | EP1601782A2 Diagnostics and therapeutics for diseases associated with human phosphodiesterase 8b (pde8b) |
12/07/2005 | EP1601779A2 Carboxylic acid reductase polypeptide, nucleotide sequence encoding same and methods of use |
12/07/2005 | EP1601777A2 Methods to enhance the activity of lignocellulose-degrading enzymes |
12/07/2005 | EP1601774A2 Gdc-2 genes conferring herbicide resistance |
12/07/2005 | EP1601773A2 Nucleotide sequences of coryneform bacteria coding for proteins involved in l-serine metabolism and method for producing l-serine |
12/07/2005 | EP1601772A1 Modified tert promoter with enhanced tumor-specificity and strength and recombinant vector comprising the same |
12/07/2005 | EP1601765A2 Variants of enzymes of the alpha-amylase family |
12/07/2005 | EP1601764A2 A class of metacaspases |
12/07/2005 | EP1601761A1 Improved protein secretion in eukaryotic cells |
12/07/2005 | EP1601690A2 Production of plants with improved digestibility having an inactive peroxidase |
12/07/2005 | EP1601684A2 Compositions and methods employing alternative reading frame polypeptides for the treatment of cancer and infectious disease |
12/07/2005 | EP1601332A2 Hydrolases, nucleic acids encoding them and mehods for making and using them |
12/07/2005 | EP1373479A4 Methods for monitoring prothease inhibitor antiretroviral therapy |
12/07/2005 | EP1266006B1 Production of recombinant muteins of blood clotting factor viii in human cell lines |